Susquehanna International Group, LLP Rigel Pharmaceuticals Inc Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$1.12 - $1.57 $185,926 - $260,629	-166,006 Reduced 55.34%	133,952 $198,000
Q4 2023 Feb 14, 2024	BUY	$0.72 - $1.56 $37,314 - $80,848	51,826 Added 20.89%	299,958 $434,000
Q3 2023 Nov 14, 2023	SELL	$1.07 - $1.39 $566,780 - $736,284	-529,701 Reduced 68.1%	248,132 $267,000
Q2 2023 Aug 11, 2023	BUY	$1.12 - $1.82 $684,453 - $1.11 Million	611,119 Added 366.57%	777,833 $1 Million
Q1 2023 May 16, 2023	SELL	$1.25 - $2.0 $42,076 - $67,322	-33,661 Reduced 16.8%	166,714 $220,000
Q4 2022 Feb 14, 2023	BUY	$0.67 - $11.9 $54,814 - $973,574	81,813 Added 69.0%	200,375 $300,000
Q3 2022 Nov 14, 2022	SELL	$1.1 - $12.2 $212,737 - $2.36 Million	-193,398 Reduced 61.99%	118,562 $140,000
Q2 2022 Aug 15, 2022	BUY	$0.67 - $3.19 $80,270 - $382,181	119,806 Added 62.35%	311,960 $353,000
Q1 2022 May 16, 2022	SELL	$2.22 - $3.45 $730,741 - $1.14 Million	-329,163 Reduced 63.14%	192,154 $575,000
Q4 2021 Feb 14, 2022	BUY	$2.36 - $3.57 $292,330 - $442,212	123,869 Added 31.17%	521,317 $1.38 Million
Q3 2021 Nov 15, 2021	SELL	$3.5 - $4.5 $263,816 - $339,192	-75,376 Reduced 15.94%	397,448 $1.44 Million
Q2 2021 Aug 11, 2021	BUY	$3.09 - $4.54 $594,994 - $874,199	192,555 Added 68.7%	472,824 $2.05 Million
Q1 2021 May 17, 2021	BUY	$3.35 - $4.93 $249,541 - $367,235	74,490 Added 36.2%	280,269 $959,000
Q4 2020 Feb 16, 2021	SELL	$2.35 - $3.74 $207,777 - $330,675	-88,416 Reduced 30.05%	205,779 $720,000
Q3 2020 Nov 16, 2020	BUY	$1.78 - $4.13 $389,430 - $903,565	218,781 Added 290.11%	294,195 $706,000
Q2 2020 Aug 14, 2020	SELL	$1.41 - $2.05 $10,916 - $15,871	-7,742 Reduced 9.31%	75,414 $138,000
Q1 2020 May 15, 2020	BUY	$1.27 - $3.0 $61,628 - $145,578	48,526 Added 140.13%	83,156 $130,000
Q4 2019 Feb 14, 2020	SELL	$1.6 - $2.43 $92,864 - $141,037	-58,040 Reduced 62.63%	34,630 $74,000
Q3 2019 Nov 14, 2019	SELL	$1.63 - $2.62 $67,623 - $108,695	-41,487 Reduced 30.92%	92,670 $173,000
Q2 2019 Aug 16, 2019	BUY	$2.02 - $2.61 $112,760 - $145,695	55,822 Added 71.26%	134,157 $350,000
Q2 2019 Aug 14, 2019	SELL	$2.02 - $2.61 $260,733 - $336,888	-129,076 Reduced 62.23%	78,335 $204,000
Q4 2018 Feb 14, 2019	BUY	$2.08 - $3.36 $322,152 - $520,400	154,881 Added 294.84%	207,411 $477,000
Q4 2017 Feb 14, 2018	BUY	$3.23 - $4.3 $109,132 - $145,284	33,787 Added 180.26%	52,530 $204,000
Q3 2017 Nov 14, 2017	BUY	$2.18 - $2.57 $40,859 - $48,169	18,743	18,743 $48,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account